The Year 3000

First published in 1897, The Year 3000 is the most daring and original work of fiction by the prominent Italian anthropologist Paolo Mantegazza. A futuristic utopian novel, the book follows two young lovers who, as they travel from Rome to the capital of the United Planetary States to celebrate their “mating union,” encounter the marvels of cultural and scientific advances along the way. Intriguing in itself, The Year 3000 is also remarkable for both its vision of the future (predicting an astonishing array of phenomena from airplanes, artificial intelligence, CAT scans, and credit cards to controversies surrounding divorce, abortion, and euthanasia) and the window it opens on fin de siècle Europe. Published here for the first time in English, this richly annotated edition features an invaluable introductory essay that interprets the intertextual and intercultural connections within and beyond Mantegazza’s work. For its critical contribution to early science fiction and for its insights into the hopes, fears, and clash of values in the Western world of both Mantegazza’s time and our own, this book belongs among the visionary giants of speculative literature

Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy

AbstractExcessive extracellular matrix deposition progressively replacing muscle fibres is the endpoint of most severe muscle diseases. Recent data indicate major involvement of microRNAs in regulating pro- and anti-fibrotic genes. To investigate the roles of miR-21 and miR-29 in muscle fibrosis in Duchenne muscle dystrophy, we evaluated their expression in muscle biopsies from 14 patients, and in muscle-derived fibroblasts and myoblasts. In Duchenne muscle biopsies, miR-21 expression was significantly increased, and correlated directly with COL1A1 and COL6A1 transcript levels. MiR-21 expression was also significantly increased in Duchenne fibroblasts, more so after TGF-β1 treatment. In Duchenne fibroblasts the expression of miR-21 target transcripts PTEN (phosphatase and tensin homolog deleted on chromosome 10) and SPRY-1 (Sprouty homolog 1) was significantly reduced; while collagen I and VI transcript levels and soluble collagen production were significantly increased. MiR-29a and miR-29c were significantly reduced in Duchenne muscle and myoblasts, and miR-29 target transcripts, COL3A1, FBN1 and YY1, significantly increased. MiR-21 silencing in mdx mice reduced fibrosis in the diaphragm muscle and in both Duchenne fibroblasts and mdx mice restored PTEN and SPRY-1 expression, and significantly reduced collagen I and VI expression; while miR-29 mimicking in Duchenne myoblasts significantly decreased miR-29 target transcripts. These findings indicate that miR-21 and miR-29 play opposing roles in Duchenne muscle fibrosis and suggest that pharmacological modulation of their expression has therapeutic potential for reducing fibrosis in this condition

A New Thiopurine S-Methyltransferase Haplotype Associated With Intolerance to Azathioprine

n/

E-ELT M4 adaptive unit final design and construction: a progress report

The E-ELT M4 adaptive unit is a fundamental part of the E-ELT: it provides the facility level adaptive optics correction that compensates the wavefront distortion induced by atmospheric turbulence and partially corrects the structural deformations caused by wind. The unit is based on the contactless, voice-coil technology already successfully deployed on several large adaptive mirrors, like the LBT, Magellan and VLT adaptive secondary mirrors. It features a 2.4m diameter flat mirror, controlled by 5316 actuators and divided in six segments. The reference structure is monolithic and the cophasing between the segments is guaranteed by the contactless embedded metrology. The mirror correction commands are usually transferred as modal amplitudes, that are checked by the M4 controller through a smart real-time algorithm that is capable to handle saturation effects. A large hexapod provides the fine positioning of the unit, while a rotational mechanism allows switching between the two Nasmyth foci. The unit has entered the final design and construction phase in July 2015, after an advanced preliminary design. The final design review is planned for fall 2017; thereafter, the unit will enter the construction and test phase. Acceptance in Europe after full optical calibration is planned for 2022, while the delivery to Cerro Armazones will occur in 2023. Even if the fundamental concept has remained unchanged with respect to the other contactless large deformable mirrors, the specific requirements of the E-ELT unit posed new design challenges that required very peculiar solutions. Therefore, a significant part of the design phase has been focused on the validation of the new aspects, based on analysis, numerical simulations and experimental tests. Several experimental tests have been executed on the Demonstration Prototype, which is the 222 actuators prototype developed in the frame of the advanced preliminary design. We present the main project phases, the current design status and the most relevant results achieved by the validation tests

Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab

The efficacy and tolerability of eculizumab were assessed in REGAIN, a 26-week, phase 3, randomized, double-blind, placebo-controlled study in anti-acetylcholine receptor antibody-positive (AChR+) refractory generalized myasthenia gravis (gMG), and its open-label extension

Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial

Background: Preliminary evidence suggests that palliative care may be useful for people with severe multiple sclerosis (MS). The aim of this study is to determine the effectiveness of a home-based palliative approach (HPA) for people with severe MS and their carers. Methods/design: This is a single-blind randomized controlled trial with a nested qualitative study. Seventy-five severe MS-carer dyads are being randomized (at three centers, one in each area of Italy) to HPA or usual care (UC) in a 2:1 ratio. Each center has a specially trained team consisting of four professionals (physician, nurse, psychologist, social worker). The team makes a comprehensive assessment of the needs of the dyads. HPA content is then agreed on, discussed with the patient's caring physician, and delivered over six months. The intervention is not intended to replace existing services. At later visits, the team checks the HPA delivery and reviews/modifies it as necessary. Discussion: The results of our study will show whether the HPA is feasible and beneficial to people with severe MS and their carers living in the three Italian geographic areas. The nested qualitative study will add to the understanding of the strengths and limitations of the intervention

Conmemoración de Charles Darwin (1882)

Tres semanas después de la muerte del biólogo y naturalista inglés, Paolo Mantegazza pronunció el 21 de mayo de 1882 su "Conmemoración de Charles Darwin celebrada en el Real Instituto de Estudios Superiores en Florencia". Traducción de Juan Pérez Andrés